Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SUDs (single-use devices) questions on US adverse event forms "within 6 months"

This article was originally published in Clinica

Executive Summary

US hospitals and manufacturers have been given a six-month grace period to alter their adverse event reporting systems before they must file a revised MedWatch form with the FDA. The agency ordered the changes in both the mandatory and voluntary adverse event reporting forms to comply with a provision of the Medical Device User Fee and Modernization Act.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT057415

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel